The results of this meta-analysis suggest that the ERCC1 rs3212986 and ERCC2 rs13181 polymorphism polymorphisms was significantly associated with increased risk of glioma in Chinese population, but no association in Caucasian Chinese. Here, ERCC2 is linked to central nervous system cancer.